{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:46:10Z","timestamp":1792557970987,"version":"4.5.0"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,9,4]]},"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Diabetes-related distress is present in a high proportion of people with type 2 diabetes mellitus. We hypothesized that complexity of the antidiabetic medication regimen is a factor that is associated with diabetes-related distress.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>This was a retrospective study including a group of 74 patients managed at a tertiary care center. Patients with type 1 diabetes mellitus, steroid-induced diabetes, post-transplant diabetes, and other types of diabetes were excluded. Patients were screened using the Diabetes Distress Scale-2 (DDS-2). A Diabetes Medication Complexity Scoring (DMCS) system was developed to objectively assess the diabetes medication complexity. Based on DMCS, participants were categorized into three groups: low (n=26), moderate (n=22), and high (n=26) medication complexity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Complexity groups were similar in sociodemographic characteristics, diabetes duration, body mass index, and blood pressure as well as the prevalence of hypertension, hyperlipidemia and hypoglycemic episodes. However, there were significant differences for HbA1c with higher HbA1c in the high and moderate complexity groups than in the low group (p=0.006). The microvascular complications were also more common in higher complexity groups (p=0.003). The prevalence of diabetes-related distress (DDS-2 \u22656) was 34.6% in the low, 36.4% in the moderate and 69.2% in the high complexity groups (p=0.021). There were significant differences in DDS-2 score among complexity groups (p=0.009), with higher DDS-2 score in the high complexity group compared with the moderate (p=0.008) and low complexity groups (p=0.009). The difference in DDS-2 score remained significant after adjusting for HbA1c (p=0.024) but did not reach statistical significance after controlling for both HbA1c and microvascular complications (p=0.163).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A complex antidiabetic medication regimen may be associated with high levels of diabetes-related distress.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2021-002348","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:16:42Z","timestamp":1633047402000},"page":"e002348","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus"],"prefix":"10.1136","volume":"9","author":[{"given":"Maria","family":"Luzuriaga","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miller School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Leite","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Miami, Coral Gables, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miller School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice G","family":"Saab","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Miami, Coral Gables, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-1619","authenticated-orcid":false,"given":"Rajesh","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miller School of Medicine, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"2025073112141210000_9.1.e002348.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2053"},{"key":"2025073112141210000_9.1.e002348.2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/dme.13448","article-title":"The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis","volume":"34","author":"Perrin","year":"2017","journal-title":"Diabet Med"},{"key":"2025073112141210000_9.1.e002348.3","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1238"},{"key":"2025073112141210000_9.1.e002348.4","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2013-203063"},{"key":"2025073112141210000_9.1.e002348.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26138-5","article-title":"Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National diabetes audit (ANDA) 2016","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci Rep"},{"key":"2025073112141210000_9.1.e002348.6","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1452."},{"key":"2025073112141210000_9.1.e002348.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000685"},{"key":"2025073112141210000_9.1.e002348.8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s13300-020-00838-6","article-title":"Chronic Medication Burden and Complexity for US Patients with Type\u00a02 Diabetes Treated with Glucose-Lowering Agents","volume":"11","author":"Boye","year":"2020","journal-title":"Diabetes Ther"},{"key":"2025073112141210000_9.1.e002348.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S009"},{"key":"2025073112141210000_9.1.e002348.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S012"},{"key":"2025073112141210000_9.1.e002348.11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.6.754"},{"key":"2025073112141210000_9.1.e002348.12","first-page":"626","article-title":"Assessing psychosocial distress in diabetes","volume":"28","author":"Polonsky","year":"2005","journal-title":"Development of the Diabetes Distress Scale"},{"key":"2025073112141210000_9.1.e002348.13","doi-asserted-by":"publisher","DOI":"10.1370\/afm.842"},{"key":"2025073112141210000_9.1.e002348.14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1060028016673652","article-title":"Medication regimen complexity and A1c goal attainment in underserved adults with type 2 diabetes","volume":"51","author":"Yeh","year":"2017","journal-title":"Ann Pharmacother"},{"key":"2025073112141210000_9.1.e002348.15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jdiacomp.2015.11.010","article-title":"Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes","volume":"30","author":"Winchester","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2025073112141210000_9.1.e002348.16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1054773820951933","article-title":"The association between diabetes complications, diabetes distress, and depressive symptoms in patients with type 2 diabetes mellitus","volume":"30","author":"Yang","year":"2021","journal-title":"Clin Nurs Res"},{"key":"2025073112141210000_9.1.e002348.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0331"},{"key":"2025073112141210000_9.1.e002348.18","doi-asserted-by":"crossref","unstructured":"ARUNACHALAM A , GARG R . 880-P: insulin regimen and glycemic control in people with type 2 diabetes mellitus. Am Diabetes Assoc 2021.","DOI":"10.2337\/db21-880-P"},{"key":"2025073112141210000_9.1.e002348.19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4158\/EP-2019-0303","article-title":"De-intensification of diabetes treatment in elderly patients with type 2 diabetes mellitus","volume":"25","author":"Pirela","year":"2019","journal-title":"Endocr Pract"},{"key":"2025073112141210000_9.1.e002348.20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pcd.2019.04.001","article-title":"Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Perrin","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"2025073112141210000_9.1.e002348.21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/00981389.2014.884038","article-title":"Factors associated with diabetes-related distress: implications for diabetes self-management","volume":"53","author":"Wardian","year":"2014","journal-title":"Soc Work Health Care"},{"key":"2025073112141210000_9.1.e002348.22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.pec.2018.03.001","article-title":"Who's distressed? A comparison of diabetes-related distress by type of diabetes and medication","volume":"101","author":"Wardian","year":"2018","journal-title":"Patient Educ Couns"},{"key":"2025073112141210000_9.1.e002348.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02028.x"},{"key":"2025073112141210000_9.1.e002348.24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12160-013-9585-4","article-title":"Diabetes burden and diabetes distress: the buffering effect of social support","volume":"48","author":"Baek","year":"2014","journal-title":"Ann Behav Med"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:14:22Z","timestamp":1753989262000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,30]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/bmjdrc-2021-002348"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002348","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}